Home

  • Order to parcel locker

    Order to parcel locker

  • easy pay

    easy pay
  • Reduced price
Advances in Oncology, 2024

Advances in Oncology, 2024

9780443247002
937.39 zł
796.78 zł Save 140.61 zł Tax included
Lowest price within 30 days before promotion: 796.78 zł
Quantity
Available in 4-6 weeks

  Delivery policy

Choose Paczkomat Inpost, Orlen Paczka, DHL, DPD or Poczta Polska. Click for more details

  Security policy

Pay with a quick bank transfer, payment card or cash on delivery. Click for more details

  Return policy

If you are a consumer, you can return the goods within 14 days. Click for more details

Description
Advances in Oncology reviews the year’s most important findings and updates within the field in order to provide practicing oncologists with the current clinical information they need to improve patient outcomes. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.
Product Details
Elsevier
100429
9780443247002
9780443247002

Data sheet

Publication date
2024
Issue number
1
Cover
hard cover
Pages count
240
Dimensions (mm)
191 x 235
Weight (g)
800
  • 1. Contemporary Management of Dermatofibrosarcoma Protuberans
    2. Management of Locoregional Melanoma
    3. Current Management of Intraductal Papillary Mucinous Neoplasms
    4. Perioperative Strategies in Non-Small Cell Lung Cancer: Immunotherapy and Targeted Therapy
    5. Optimal Front-Line Therapy for Non[1]Oncogene-Driven Non-Small Cell Lung Cancer
    6. Beyond First-Line Epidermal Growth Factor Receptor (EGFR)-Tyrosine Kinase Inhibitors (TKI): Approach to Resistance
    7. Antibody-Drug Conjugates for the Treatment of Gynecologic Cancer: A Review of the Current Evidence and Clinical Application
    8. Surgery for Recurrent Ovarian Cancer
    9. Big Data in Pediatric Oncology: Hope, Hype, Reality
    10. Imipridones and Dopamine Receptor Antagonism in the Therapeutic Management of Gliomas
    11. Diagnostic and Theranostic Opportunities in Neuro-Oncology
    12. Updates on Revised Diagnostic Criteria and Targeted Therapies for Neurofibromatosis
    13. Management of Relapsed Refractory Large B[1]Cell Non-Hodgkin Lymphoma: Chimeric Antigen Receptor T-Cell Therapy versus Autologous Stem Cell Transplantation
    14. T-cell Acute Lymphoblastic Leukemia: Novel Therapies Worth Watching
    15. Prognostic Role and Clinical Utility of Measurable Residual Disease in Acute Myeloid Leukemia
    16. Role of Circulating Tumor DNA for Monitoring of Recurrence and Treatment Response in Urothelial Cancer
    17. Intensification of Androgen Deprivation Therapy in Metastatic Hormone-sensitive Prostate Cancer: 18. Patient Selection and Overview of Doublet and Triplet Therapy Data
    19. Adjuvant Therapy for Muscle-Invasive Urothelial Cancer: Current Evidence and Future Directions
    20. Defining the Role of Neoadjuvant Therapy for Gastroesophageal Cancers
    21. Current and Emerging Therapeutic Options for Human Epidermal Growth Factor Receptor 2-Expressing Gastroesophageal Cancers
    22. Contemporary Systemic Therapy Approaches for Unresectable Hepatocellular Carcinoma
    23. Multidisciplinary Care and Multimodal Treatment Approaches for Unresectable Hepatocellular Carcinoma
Comments (0)